TY - JOUR T1 - Selatogrel and other P2Y12 inhibitors鈥� putative off-target effects JO - Journal of Cardiovascular Pharmacology PY - 2021/08/31 AU - Valgimigli M AU - Storey RF AU - Sinnaeve PR AU - Riederer MA AU - Bernaud C AU - Frenoux J-M ED - DO - DOI: 10.1097/fjc.0000000000001135 PB - Ovid Technologies (Wolters Kluwer Health) VL - Publish Ahead of Print Y2 - 2025/07/07 ER -